Genome Editing in Drug Discovery. Группа авторов
Чтение книги онлайн.

Читать онлайн книгу Genome Editing in Drug Discovery - Группа авторов страница 20

Название: Genome Editing in Drug Discovery

Автор: Группа авторов

Издательство: John Wiley & Sons Limited

Жанр: Биология

Серия:

isbn: 9781119671398

isbn:

СКАЧАТЬ within the PAM or protospacer.

      Thanks to the greater availability of prokaryotic genome sequences, bioinformatic analysis has revealed that CRISPR systems are extremely abundant in prokaryotes, with roughly 40% of bacterial and over 85% of archaeal species harboring these systems (Makarova et al. 2019). This diversity, conferred by the remarkable variety of the Cas protein sequences, gene composition, and architecture of the loci, underpins the differences in how each of the three phases of adaptive immunity is performed. CRISPR systems have not only evolved to use different types of nucleic acids (DNA, RNA, or both) as a substrate (Marraffini and Sontheimer 2008; Hale et al. 2009; Kazlauskiene et al. 2016), but also can target different modalities (i.e. single‐ or double‐stranded) (Ma et al. 2015; Strutt et al. 2018) and a wide spectrum of different genomic sequences, thanks to diverse PAM requirements (Mojica et al. 2009; Gasiunas et al. 2020).

      Importantly, the diversity of Cas systems across species also translates into how these systems can be used as a tool, where one can choose the most suitable CRISPR system for their target (DNA or RNA), a sequence of choice (by choosing a Cas protein with a pertinent PAM) or application (by choosing a Cas system with the desired outcome). To fully explore this untapped potential of the microbial CRISPR systems, significant efforts to establish a robust classification of CRISPR‐Cas systems have been made over the past decade. As there are no universally present cas genes that could act as an identifying trait, CRISPR classifications have been based on multiple factors, mainly on comparison of genomic loci organization and gene repertoires involved in a particular system. The most up‐to‐date classification is used in this chapter (Makarova et al. 2019).

      While the interference module is the prominent feature in the classification of CRISPR systems, each of the classes and types also differ mechanistically in the manners of crRNA biogenesis and acquisition of spacers. The traits of main CRISPR‐Cas systems will be discussed, with some differences between different subtypes touched upon as well; however, the intricacies and finesses of further classification are beyond the scope of this Chapter and the reader is invited to consult recent excellent reviews on the topic (Hille et al. 2018; Koonin and Makarova 2019; Makarova et al. 2019; Nussenzweig and Marraffini 2020).

      3.3.1 crRNA Biogenesis

      In class 1 systems, the processing is performed by either Cas6 or Cas5d ribonucleases (Nam et al. 2012; Carte et al. 2008). Both of these proteins recognize and bind to the hairpin structure formed by the palindromic sequences of the pre‐cRNA, and introduce a cut immediately downstream of it (Figure 3.3a), releasing mature crRNAs (Carte et al. 2010; Haurwitz et al. 2010; Ozcan et al. 2019). Intriguingly, in CRISPR systems containing repeats which are not thermodynamically likely to form hairpin structures (namely type I‐A and ‐B, and type III‐A and ‐B) and, hence, lack inherent discriminatory borders between spacers, Cas6 seems to be able to identify repeat regions by restructuring them to favor the formation of a hairpin or hairpin‐like structure compatible with precise cleavage that will lead to productive crRNAs (Shao et al. 2016; Sefcikova et al. 2017). Mature crRNAs of most type I systems contain part of the repeat sequence at the 5’ end of the spacer and the 3’ hairpin; these do not participate in recognition of the target sequence but seem to be important for the assembly of the effector complex (Jore et al. 2011). Type III crRNA, on the other hand, undergoes additional trimming that removes the hairpin structure (Hale et al. 2008). How these mature crRNAs are paired to the cognate effector complex remains unanswered.

      Class 2 systems employ two different strategies to generate mature crRNAs. The first strategy employed by type V and VI is in principle similar to class 1 crRNA biogenesis (Figure 3.3b). Here, the effector nucleases, such as Cas12a (Cpf1) and Cas13, recognize the repeat hairpin structure within the pre‐crRNA and cleave the RNA within or upstream of it (East‐Seletsky et al. 2016; Fonfara et al. 2016).

Schematic illustration of an overview of class 1 and class 2 CRISPR systems.